SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (2751)6/4/2012 11:48:15 AM
From: software salesperson  Read Replies (1) | Respond to of 3202
 
Conventional therapy

 Chemotherapy

 Local radiation

Immune Modulators

 Anti-CTLA-4

 Anti-PD1

 Treg inhibitors: anti-CD25

 IDO inhibitors

 TGF-ß and IL-10 inhibitors

 Immune activating cytokines: IL-2, IL-15, IL-12, IL-21…

 TLR agonists

 Flt3 ligand – DC growth factor

 Anti-CD27 mAb – T cell co-stimulation

cancerprogressbydh.com



To: scaram(o)uche who wrote (2751)6/4/2012 11:41:49 PM
From: Biomaven  Read Replies (3) | Respond to of 3202
 
Any clue if IDO inhibitor might be complementary with anti-PD-1?

Peter